Letter | Published:

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

Abstract

Bacterial infection of the mammalian bloodstream can lead to overwhelming sepsis, a potentially fatal syndrome of irreversible cardiovascular collapse (shock) and critical organ failure. Cachectin, also known as tumour necrosis factor, is a macrophage-derived peptide hormone released in response to bacterial lipopolysaccharide, and it has been implicated as a principal mediator of endotoxic shock, although its function in bacterial sepsis is not known. Anaesthetized baboons were passively immunized against endogenous cachectin and subsequently infused with an LD100 dose of live Escherichia coli. Control animals (not immunized against cachectin) developed hypotension followed by lethal renal and pulmonary failure. Neutralizing monoclonal anti-cachectin antibody fragments (F(ab′)2) administered to baboons only one hour before bacterial challenge protected against shock, but did not prevent critical organ failure. Complete protection against shock, vital organ dysfunction, persistent stress hormone release and death was conferred by administration of antibodies 2 h before bacterial infusion. These results indicate that cachectin is a mediator of fatal bacteraemic shock, and suggest that antibodies against cachectin offer a potential therapy of life-threatening infection.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    1. Kreger, B. E. W., Craven, D. E. & McCabe, W. R. Am. J. Med. 68, 344-355 (1980). 2. Ziegler, E. J. el al New Engl. J. Med, 307, 1225-1230 (1982). 3. Gilbert, R. P. Physiol. Rev. 40, 245-279 (1960). 4. Beutler, B. & Cerami, A. Nature 320, 584-588 (1986). 5. Beutler, B. & Cerami, A. New Engl. J. Med. 316, 379-385 (1987). 6. Tracey, K. J., Lowry, S. F. & Cerami, A. in TNF and Related Cytotoxins. CIBA Found. Symp. 131, 88-108 (Wiley, London, 1987). 7. Tracey, K. J., Lowry, S. F. & Cerami, A. J. infect. Dis. (in the press). 8. Beutler, B., Milsark, I. W. & Cerami, A. J. Immun. 135, 3972-3977 (1985). 9. Tracey, K. J. et al. Science 234, 470-474 (1986). 10. Tracey, K. J. et al. Surg. gynecol. Obstet. 164, 415-422 (1987). 11. Beutler, B., Milsark, I. W. & Cerami, A. Science 229, 869-871 (1985). 12. Cryer, P. E., Herman, C. M. & Sode, J. Ann. Surg. 174, 91-100 (1971). 13. Coalson, J. J., Hinshaw, L. B., Guenter, C. A., Berrel, E. L. & Greenfield, L. J. Lab. Invest. 32, 561-569 (1975). 14. Hesse, D. G. et al. Surg. gynecol. Obstet. (in the press). 15. Lowry, S. F. in Advances in Host Defense Mechanisms Vol. 6 (eds Gallin, J. I. & Fauci, A. S.) 169-190 (Raven, New York, 1986). 16. McCabe, W. R. New Engl. J. Med. 288, 21-23 (1973). 17. Dinarello, C. A. et al. J. exp. Med. 163, 1433-1450 (1986). 18. Darius, H., Lefer, D. J., Smith, J. B. & Lefer, A. M. Science 232, 58-60 (1986). 19. Chang, S. W., Feddersen, C. O., Henson, P. M. & Voelkel, N. F. J. din. Invest. 79,1498-1509 (1987). 20. Scuderi, P. et al. Lancet ii, 1364-1365 (1986). 21. Tracey, K. J. et al. Surg. Forum 37, 13-15 (1986). 22. Waage, A., Halstensen, A. & Espevik, T. Lancet i, 355-357 (1987). 23. Pool, J. L. Surg. gynecol. Obstet. 132, 1-9 (1971). 24. Parham, P. J. Immun. 131, 2895-2899 (1983). 25. Peters, P. M. et al. J. Immun. 137, 2592-2598 (1986). 26. Carswell, E. A. et al. Proc. natn. Acad. Sci. U.S.A. 72, 3666-3670 (1975). 27. Passon, P. G. & Peuler, J. D. Analyt. Biochem. 51, 618-631 (1973). 28. Aquilar-Parada, A., Eisentraut, E. M. & Unger, R. H. Diabetes 18, 717-723 (1969).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.